QR code

Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the newly emergent causative agent of coronavirus disease-19 (COVID-19), has resulted in more than two million deaths worldwide since it was first detected in 2019. There is a critical global need for therapeutic intervention strategies t...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Allison Bakovic, Kenneth Risner, Nishank Bhalla, Farhang Alem, Theresa L. Chang, Warren K. Weston, Jane A. Harness, Aarthi Narayanan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2021-02-01
Reeks:Viruses
Onderwerpen:
brilacidin
coronavirus
antiviral
defensin
peptidomimetic
entry inhibition
Online toegang:https://www.mdpi.com/1999-4915/13/2/271
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items